Study: NCT00535730

Adverse event: Chronic obstructive pulmonary disease
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 236 at risk

Adverse event: Non-Hodgkin's lymphoma
Serious: yes
Organ System: Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Frequency: 1 affected / 236 at risk

Adverse event: Haematoma
Serious: yes
Organ System: Vascular disorders
Frequency: 1 affected / 236 at risk

Adverse event: Diverticulitis
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 236 at risk

Adverse event: Amnesia
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 236 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 3 affected / 236 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 3 affected / 236 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Frequency: 3 affected / 236 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Frequency: 1 affected / 236 at risk

Adverse event: Nasopharyngitis
Serious: no
Organ System: Infections and infestations
Frequency: 5 affected / 236 at risk

Adverse event: Upper respiratory tract infection
Serious: no
Organ System: Infections and infestations
Frequency: 1 affected / 236 at risk

Adverse event: Urinary tract infection
Serious: no
Organ System: Infections and infestations
Frequency: 4 affected / 236 at risk

Adverse event: Arthralgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 3 affected / 236 at risk

Adverse event: Back pain
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 5 affected / 236 at risk

Adverse event: Musculoskeletal pain
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 3 affected / 236 at risk

Adverse event: Myalgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 4 affected / 236 at risk

Adverse event: Pain in extremity
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 4 affected / 236 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 4 affected / 236 at risk

Adverse event: Laryngeal pain
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 4 affected / 236 at risk

Adverse event: Erythema
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 3 affected / 236 at risk

Adverse event: Pruritus
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 3 affected / 236 at risk

Adverse event: Rash
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 6 affected / 236 at risk

Adverse event: Rash vesicular
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 4 affected / 236 at risk

Adverse event: Erythema (ZOSTAVAX™ injection site)
Serious: no
Organ System: General disorders
Frequency: 70 affected / 236 at risk

Adverse event: Erythema (PNEUMOVAX™ 23 injection site)
Serious: no
Organ System: General disorders
Frequency: 30 affected / 236 at risk

Adverse event: Erythema (Placebo injection site)
Serious: no
Organ System: General disorders
Frequency: 7 affected / 236 at risk

Adverse event: Induration (ZOSTAVAX™ injection site)
Serious: no
Organ System: General disorders
Frequency: 3 affected / 236 at risk

Adverse event: Pain (ZOSTAVAX™ injection site)
Serious: no
Organ System: General disorders
Frequency: 68 affected / 236 at risk

Adverse event: Pain (PNEUMOVAX™ 23 injection site)
Serious: no
Organ System: General disorders
Frequency: 82 affected / 236 at risk

Adverse event: Pain (Placebo injection site)
Serious: no
Organ System: General disorders
Frequency: 21 affected / 236 at risk

Adverse event: Pruritus (ZOSTAVAX™ injection site)
Serious: no
Organ System: General disorders
Frequency: 8 affected / 236 at risk

Adverse event: Swelling (ZOSTAVAX™ injection site)
Serious: no
Organ System: General disorders
Frequency: 63 affected / 236 at risk

Adverse event: Swelling (PNEUMOVAX™ 23 injection site)
Serious: no
Organ System: General disorders
Frequency: 30 affected / 236 at risk

Adverse event: Swelling (Placebo injection site)
Serious: no
Organ System: General disorders
Frequency: 5 affected / 236 at risk

Adverse event: Dermatitis contact
Serious: yes
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 235 at risk

Adverse event: Vertigo
Serious: yes
Organ System: Ear and labyrinth disorders
Frequency: 1 affected / 235 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 2 affected / 235 at risk

Adverse event: Abdominal discomfort
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 3 affected / 235 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Frequency: 1 affected / 235 at risk

Adverse event: Malaise
Serious: no
Organ System: General disorders
Frequency: 3 affected / 235 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Frequency: 5 affected / 235 at risk

Adverse event: Nasopharyngitis
Serious: no
Organ System: Infections and infestations
Frequency: 9 affected / 235 at risk

Adverse event: Upper respiratory tract infection
Serious: no
Organ System: Infections and infestations
Frequency: 5 affected / 235 at risk

Adverse event: Urinary tract infection
Serious: no
Organ System: Infections and infestations
Frequency: 3 affected / 235 at risk

Adverse event: Arthralgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 1 affected / 235 at risk

Adverse event: Back pain
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 3 affected / 235 at risk

Adverse event: Musculoskeletal pain
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 1 affected / 235 at risk

Adverse event: Myalgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 4 affected / 235 at risk

Adverse event: Pain in extremity
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 2 affected / 235 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 13 affected / 235 at risk

Adverse event: Cough
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 3 affected / 235 at risk

Adverse event: Laryngeal pain
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 5 affected / 235 at risk

Adverse event: Erythema
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 3 affected / 235 at risk

Adverse event: Pruritus
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 2 affected / 235 at risk

Adverse event: Rash
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 235 at risk

Adverse event: Rash vesicular
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 3 affected / 235 at risk

Adverse event: Erythema (ZOSTAVAX™ injection site)
Serious: no
Organ System: General disorders
Frequency: 72 affected / 235 at risk

Adverse event: Erythema (PNEUMOVAX™ 23 injection site)
Serious: no
Organ System: General disorders
Frequency: 46 affected / 235 at risk

Adverse event: Erythema (Placebo injection site)
Serious: no
Organ System: General disorders
Frequency: 1 affected / 235 at risk

Adverse event: Induration (ZOSTAVAX™ injection site)
Serious: no
Organ System: General disorders
Frequency: 2 affected / 235 at risk

Adverse event: Pain (ZOSTAVAX™ injection site)
Serious: no
Organ System: General disorders
Frequency: 74 affected / 235 at risk

Adverse event: Pain (PNEUMOVAX™ 23 injection site)
Serious: no
Organ System: General disorders
Frequency: 95 affected / 235 at risk

Adverse event: Pain (Placebo injection site)
Serious: no
Organ System: General disorders
Frequency: 8 affected / 235 at risk

Adverse event: Pruritus (ZOSTAVAX™ injection site)
Serious: no
Organ System: General disorders
Frequency: 11 affected / 235 at risk

Adverse event: Swelling (ZOSTAVAX™ injection site)
Serious: no
Organ System: General disorders
Frequency: 67 affected / 235 at risk

Adverse event: Swelling (PNEUMOVAX™ 23 injection site)
Serious: no
Organ System: General disorders
Frequency: 49 affected / 235 at risk

Adverse event: Swelling (Placebo injection site)
Serious: no
Organ System: General disorders
Frequency: 3 affected / 235 at risk